Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 7
Submit an article Journal homepage
1,102
Views
1
CrossRef citations to date
0
Altmetric
Coronavirus – Letter

Evaluation of immunogenicity post two doses of inactivated SARS-CoV-2 vaccine, Covaxin after six months

Rima R. Sahaya Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, IndiaView further author information
,
Pragya D. Yadava Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, IndiaCorrespondence[email protected]
View further author information
,
Ashok Nandapurkarb Aundh Chest Hospital, Pimpri-Chinchwad, Pune, IndiaView further author information
,
Rutuja Dhawdea Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, IndiaView further author information
,
Annasaheb Suryawanshia Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, IndiaView further author information
,
Deepak Y. Patila Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, IndiaView further author information
,
Anita M. Shetea Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, IndiaView further author information
,
Gajanan N. Sapkala Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, IndiaView further author information
,
Milind Kulkarnib Aundh Chest Hospital, Pimpri-Chinchwad, Pune, IndiaView further author information
,
Yogesh K. Gurava Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, IndiaView further author information
,
Gururaj R. Deshpandea Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, IndiaView further author information
,
Jagdevi S. Ghodkeb Aundh Chest Hospital, Pimpri-Chinchwad, Pune, IndiaView further author information
,
Rajlaxmi Jaina Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, IndiaView further author information
,
Raj Hawalea Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, IndiaView further author information
,
Kaumudi Kalelea Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, IndiaView further author information
,
Jyoti Yemula Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, IndiaView further author information
,
Pranita Gawandea Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, IndiaView further author information
&
Priya Abrahama Maximum Containment Facility, Indian Council of Medical Research-National Institute of Virology, Pune, IndiaView further author information
 show all
Article: 2156753 | Received 23 Oct 2022, Accepted 06 Dec 2022, Published online: 28 Dec 2022

References

  • Fisayo T, Tsukagoshi S. Three waves of the COVID-19 pandemic. Postgrad Med J. 2021 May 1;97(1147):332. doi:10.1136/postgradmedj-2020-138564.
  • Bogam P, Joshi A, Nagarkar S, Jain D, Gupte N, Shashidhara LS, Monteiro JM, Mave V. Burden of COVID-19 and case fatality rate in Pune, India: an analysis of the first and second wave of the pandemic. IJID Regions. 2022;2:74–4. doi:10.1016/j.ijregi.2021.12.006.
  • Nagy A, Alhatlani B. An overview of current COVID-19 vaccine platforms. Comput Struct Biotechnol J. 2021;19:2508–17. doi:10.1016/j.csbj.2021.04.061.
  • Ella R, Vadrevu KM, Jogdand H, Prasad S, Reddy S, Sarangi V, Ganneru B, Sapkal G, Yadav P, Abraham P, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial. Lancet Infect Dis. 2021;21(5):637–46. doi:10.1016/S1473-3099(20)30942-7.
  • World Health Organization. Annexes to the interim recommendations for use of the bharat biotech BBV152 COVAXIN® vaccine against COVID-19. [accessed 2022 Sep15]. https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE-recommendation-bbv152-covaxin-annexes.
  • Arora G, Taneja J, Bhardwaj P, Goyal S, Naidu K, Yadav SK, Saluja D, Jetly S. Adverse events and breakthrough infections associated with COVID-19 vaccination in the Indian population. J Med Virol. 2022;94(7):3147–54. doi:10.1002/jmv.27708.
  • Menni C, May A, Polidori L, Louca P, Wolf J, Capdevila J, Hu C, Ourselin S, Steves CJ, Valdes AM, et al. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID study. Lancet Infect Dis. 2022 Apr 8;22(7):1002–10. doi:10.1016/S1473-3099(22)00146-3.
  • Deshpande G, Kaduskar O, Deshpande K, Bhatt V, Yadav PD, Gurav Y, Potdar V, Khutwad K, Vidhate S, Salunke A, et al. Longitudinal clinic-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2. Int J Infect Dis. 2021;112:103–10. doi:10.1016/j.ijid.2021.09.024.
  • Deshpande GR, Sapkal GN, Tilekar BN, Yadav PD, Gurav Y, Gaikwad S, Kaushal H, Deshpande KS, Kaduskar O, Sarkale P, et al. Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients. Indian J Med Res. 2020 Jul & Aug;152(1 & 2):82–87. doi:10.4103/ijmr.IJMR_2382_20.
  • Sahay RR, Patil DY, Sapkal GN, Shete AM, Yadav PD. Cases of SARS-CoV-2 reinfection with Omicron BA. 2 post breakthrough infection with Delta and kappa variants. Infect Dis. 2022 Aug 22:1–4. doi:10.1080/23744235.2022.2114538.
  • Kumar NP, Banurekha VV, Kumar CG, Nancy A, Padmapriyadarsini C, Shankar S, Hanna LE, Murhekar M, Devi KU, Babu S. Inactivated COVID-19 vaccines: durability of Covaxin/BBV152 induced immunity against variants of concern. J Travel Med. 2022;29(6):taac088. doi:10.1093/jtm/taac088.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.